Ibnsina Pharma (EGX:ISPH)

Sage Therapeutics Ratios and Metrics

Market cap in millions EGP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	10,332	7,056	3,517	2,419	3,907	4,886
Market Cap Growth	271.13%	100.64%	45.37%	-38.08%	-20.04%	-39.01%
Enterprise Value	30,761	23,168	15,494	11,020	10,960	10,282
Last Close Price	10.25	7.00	3.14	2.16	3.28	4.10
PE Ratio	18.27	14.17	20.31	17.84	13.65	26.54
Forward PE	9.00	11.62	10.44	3.90	9.83	12.70
PS Ratio	0.17	0.13	0.10	0.11	0.18	0.26
PB Ratio	4.75	3.47	2.43	1.92	2.69	3.58
P/TBV Ratio	5.27	3.89	2.86	1.97	2.72	3.60
P/FCF Ratio	-	-	-	-	-	224.70
P/OCF Ratio	-	-	27.95	6.69	-	19.40
PEG Ratio	0.20	0.35	0.35	0.35	0.41	0.44
EV/Sales Ratio	0.49	0.42	0.46	0.50	0.50	0.55
EV/EBITDA Ratio	10.42	9.69	12.24	18.48	13.97	17.09
EV/EBIT Ratio	11.43	10.26	13.46	22.85	16.42	21.04
EV/FCF Ratio	-13.40	-	-	-	-	472.83
Debt / Equity Ratio	10.05	9.94	9.06	7.82	5.49	4.94
Debt / EBITDA Ratio	7.41	8.08	9.83	14.82	9.47	10.92
Debt / FCF Ratio	-	-	-	-	-	310.22
Asset Turnover	2.34	2.37	2.16	1.84	2.12	2.15
Inventory Turnover	9.23	10.53	10.82	8.30	9.02	9.08
Quick Ratio	0.67	0.67	0.68	0.60	0.66	0.48
Current Ratio	1.00	1.00	1.00	1.00	1.03	1.06
Return on Equity (ROE)	37.50%	35.32%	15.75%	12.60%	22.31%	17.36%
Return on Assets (ROA)	6.31%	5.98%	4.58%	2.50%	4.06%	3.51%
Return on Capital (ROIC)	8.54%	7.67%	5.60%	2.93%	4.75%	4.13%
Return on Capital Employed (ROCE)	80.40%	70.20%	43.90%	20.10%	35.40%	27.20%
Earnings Yield	5.47%	8.71%	6.08%	7.13%	8.05%	4.60%
FCF Yield	-22.23%	-16.79%	-6.49%	-18.05%	-12.49%	0.45%
Dividend Yield	-	-	-	-	2.62%	-
Payout Ratio	4.17%	4.17%	10.74%	81.35%	4.63%	36.51%
Buyback Yield / Dilution	-	-	-	22.58%	-16.25%	-
Total Shareholder Return	-	-	-	22.58%	-13.63%	-

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.